DAFNA Capital Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.79M | Sell |
|
|||||
|
2025
Q1 | $5.45M | Hold |
|
|||||
|
2024
Q4 | $5.25M | Buy |
|
|||||
|
2024
Q3 | $5.83M | Sell |
|
|||||
|
2024
Q2 | $7.87M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $42K | Sell |
|
|||||
|
2019
Q4 | $133K | Sell |
|
|||||
|
2019
Q3 | $357K | Hold |
|
|||||
|
2019
Q2 | $539K | Hold |
|
|||||
|
2019
Q1 | $554K | Hold |
|
|||||
|
2018
Q4 | $646K | Hold |
|
|||||
|
2018
Q3 | $708K | Buy |
|
|||||
|
2018
Q2 | $498K | Buy |
|
|||||
|
2018
Q1 | $224K | Buy |
|